Ligand validation:7B26

MAN: alpha-D-mannopyranose

MAN is a Ligand Of Interest in 7B26 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7B26_MAN_B_504	81%	21%	0.087	0.939	1.92	1.42	4	3	0	0	100%	0.9167
7B26_MAN_A_200	64%	25%	0.137	0.937	1.95	1.11	4	1	0	0	100%	0.9167
7B26_MAN_B_501	64%	25%	0.149	0.948	1.91	1.16	4	1	0	0	100%	0.9167
7B26_MAN_B_503	63%	23%	0.156	0.952	1.88	1.29	4	2	0	0	100%	0.9167
7B26_MAN_B_507	57%	24%	0.161	0.938	1.9	1.26	4	1	0	0	100%	0.9167
7B26_MAN_B_506	53%	27%	0.167	0.943	1.93	1.03	4	1	0	1	92%	0.9167
7B26_MAN_B_502	52%	26%	0.182	0.942	1.86	1.16	4	2	0	0	100%	0.9167
7B26_MAN_B_505	44%	24%	0.186	0.914	1.83	1.29	4	2	0	0	100%	0.9167
7B26_MAN_A_201	3%	26%	0.478	0.831	1.91	1.12	4	1	0	0	100%	0.9167
7NOZ_MAN_D_501	83%	33%	0.109	0.968	1.07	1.55	-	2	0	0	100%	0.9167
6S08_MAN_A_505	82%	43%	0.086	0.955	0.6	1.58	-	2	0	0	92%	0.9167
6S0B_MAN_A_503	79%	52%	0.097	0.958	0.44	1.38	-	2	0	0	92%	0.9167
6SEJ_MAN_B_510	74%	25%	0.117	0.948	1.13	1.88	1	2	0	0	100%	0.9167
6S0A_MAN_A_501	72%	44%	0.132	0.972	0.39	1.74	-	4	0	0	92%	0.9167
1GAI_MAN_A_480	100%	75%	0.043	0.986	0.45	0.53	-	-	0	0	100%	0.9167
5M03_MAN_A_402	100%	59%	0.034	0.989	0.56	0.99	-	-	0	0	92%	0.9167
1GAH_MAN_A_479	99%	76%	0.05	0.989	0.44	0.5	-	-	0	0	100%	0.9167
1BXO_MAN_A_328	99%	38%	0.05	0.985	1.37	1.08	1	1	0	0	100%	0.9167
7LTB_MAN_B_101	99%	59%	0.053	0.985	0.73	0.85	-	1	0	0	100%	0.9167

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.